Companies: 10,795·Total market cap: $144.5T
Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

TKPHFOTCHealthcare● Active
$32.60
+$2.13(+6.99%)
Market Cap$51.5B
P/E Ratio—
52W High$39.2
52W Low$26.33
Overview

Takeda Pharmaceutical Company Limited（TKPHF）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

tkphf · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 80.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $30.47

Takeda Pharmaceutical Company Limited（TKPHF）的分析师共识为 Buy，基于过去 3 个月内 5 位华尔街分析师的评级。TKPHF 的 12 个月平均目标价为 $0.00，相对当前价 $30.47 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$29.67↓ 2.63%

1-day model range: $29.58–$29.76. Peak: $29.76 (-2.63%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$30-1.1%
2028$30-1.9%
2029$30-2.3%
2030$30-2.6%
2031—-2.8%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)26.8Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · TKPHF · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$30.47NEUTRAL
MA 10$31.17SELL
MA 20$31.79SELL
MA 50$33.08SELL
MA 100$33.78SELL
MA 200$31.35SELL
Current $TKPHF · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$30.62SELL
EMA 10$31.01SELL
EMA 20$31.62SELL
EMA 50$32.63SELL
EMA 100$32.71SELL
EMA 200$31.77SELL
Current $TKPHF · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
TD Cowen2023-05-15
Maintains
Outperform→Outperform
TD Cowen2023-04-03
Maintains
Outperform→Outperform
B of A Securities2023-03-15
Upgrade ↑
Neutral→Buy
Cowen & Co.2022-07-18
Upgrade ↑
Market Perform→Outperform
Morgan Stanley2021-10-06
Downgrade ↓
Overweight→Equal Weight
JP Morgan2020-03-10
Maintains
Overweight→Overweight

Wall Street analysts have recently issued updated ratings on Takeda Pharmaceutical Company Limited (TKPHF) stock. Of the recent 6 rating actions, 2 were upgrades and 1 were downgrades. 5 analysts currently cover TKPHF.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

TKPHF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$4.61T

↓ 3.8% YoY

Revenue Next Year

$4.67T

↑ 1.3% YoY

EPS This Year

$138.62

EPS Next Year

$196.94

↑ 42.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TKPHF EPS of $138.62 for the current fiscal year, based on estimates from 3 analysts. The TKPHF revenue forecast is $4.61T for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

TKPHF 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TKPHF 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

TKPHF 的短期预测（明日）为 $29.67（-2.63%）。 TKPHF 对 2027 年的股价预测均值为 $30。 TKPHF 对 2030 年的预测区间为 $29–$31。

Takeda Pharmaceutical Company Limited 在 OTC 上市，代码 TKPHF。TKPHF 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

TKPHF 预测 · 8 个问题

根据 5 位华尔街分析师，TKPHF 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $30.47，隐含约 +0.0% 的上行空间。

TKPHF 目标价TKPHF 分析师目标价TKPHF 12个月目标价目标价 TKPHF

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.